Skip to main content
Top
Published in: Netherlands Heart Journal 12/2013

Open Access 01-12-2013 | Original Article-E-Learning

Low efficacy of cardioversion of persistent atrial fibrillation with the implantable cardioverter-defibrillator

Authors: I. Limantoro, K. Vernooy, B. Weijs, R. Pisters, L. Debie, H. J. Crijns, Y. Blaauw

Published in: Netherlands Heart Journal | Issue 12/2013

Login to get access

Abstract

Aims

Atrial fibrillation (AF) and heart failure are conditions that often coexist. Consequently, many patients with an implantable cardioverter-defibrillator (ICD) present with AF. We evaluated the effectiveness of internal cardioversion of AF in patients with an ICD.

Methods

Retrospectively, we included 27 consecutive ICD patients with persistent AF who underwent internal cardioversion using the ICD. When ICD cardioversion failed, external cardioversion was performed.

Results

Patients were predominantly male (89 %) with a mean (SD) age of 65 ± 9 years and left ventricular ejection fraction of 36 ± 17 %. Only nine (33 %) patients had successful internal cardioversion after one, two or three shocks. The remaining 18 patients underwent external cardioversion after they failed internal cardioversion, which resulted in sinus rhythm in all. A smaller left atrial volume (99 ± 36 ml vs. 146 ± 44 ml; p = 0.019), a longer right atrial cycle length (227 (186–255) vs. 169 (152–183) ms, p = 0.030), a shorter total AF history (2 (0–17) months vs. 40 (5–75) months, p = 0.025) and dual-coil ICD shock (75 % vs. 26 %, p = 0.093) were associated with successful ICD cardioversion.

Conclusion

Internal cardioversion of AF in ICD patients has a low success rate but may be attempted in those with small atria, a long right atrial fibrillatory cycle length and a short total AF history, especially when a dual-coil ICD is present. Otherwise, it seems reasonable to prefer external over internal cardioversion when it comes to termination of persistent AF.
Literature
1.
go back to reference Berry C, Stewart S, Payne EM, et al. Electrical cardioversion for atrial fibrillation: outcomes in “real-life” clinical practice. Int J Cardiol. 2001;81(1):29–35.PubMedCrossRef Berry C, Stewart S, Payne EM, et al. Electrical cardioversion for atrial fibrillation: outcomes in “real-life” clinical practice. Int J Cardiol. 2001;81(1):29–35.PubMedCrossRef
2.
go back to reference Blich M, Edoute Y. Electrical cardioversion for persistent or chronic atrial fibrillation: outcome and clinical factors predicting short and long term success rate. Int J Cardiol. 2006;107(3):389–94.PubMedCrossRef Blich M, Edoute Y. Electrical cardioversion for persistent or chronic atrial fibrillation: outcome and clinical factors predicting short and long term success rate. Int J Cardiol. 2006;107(3):389–94.PubMedCrossRef
3.
go back to reference Pisters R, Nieuwlaat R, Prins MH, et al. Clinical correlates of immediate success and outcome at 1-year follow-up of real-world cardioversion of atrial fibrillation: the Euro Heart Survey. Europace. 2012;14(5):666–74.PubMedCrossRef Pisters R, Nieuwlaat R, Prins MH, et al. Clinical correlates of immediate success and outcome at 1-year follow-up of real-world cardioversion of atrial fibrillation: the Euro Heart Survey. Europace. 2012;14(5):666–74.PubMedCrossRef
4.
go back to reference Turco P, D’Onofrio A, Stabile G, et al. Feasibility and efficacy of electrical cardioversion after cardiac resynchronization implantation in patients with permanent atrial fibrillation. J Interv Card Electrophysiol. 2012;35(3):331–6.PubMedCrossRef Turco P, D’Onofrio A, Stabile G, et al. Feasibility and efficacy of electrical cardioversion after cardiac resynchronization implantation in patients with permanent atrial fibrillation. J Interv Card Electrophysiol. 2012;35(3):331–6.PubMedCrossRef
5.
go back to reference Camm AJ, Kirchhof P, Lip GY, et al. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J. 2010;31(19):2369–429.PubMedCrossRef Camm AJ, Kirchhof P, Lip GY, et al. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J. 2010;31(19):2369–429.PubMedCrossRef
6.
go back to reference Crossley GH, Aonuma K, Haffajee C, et al. Atrial fibrillation therapy in patients with a CRT defibrillator with wireless telemetry. Pacing Clin Electrophysiol. 2009;32(1):13–23.PubMedCrossRef Crossley GH, Aonuma K, Haffajee C, et al. Atrial fibrillation therapy in patients with a CRT defibrillator with wireless telemetry. Pacing Clin Electrophysiol. 2009;32(1):13–23.PubMedCrossRef
7.
go back to reference Rashba EJ, Shorofsky SR, Peters RW, et al. Optimization of atrial defibrillation with a dual-coil, active pectoral lead system. J Cardiovasc Electrophysiol. 2004;15(7):790–4.PubMedCrossRef Rashba EJ, Shorofsky SR, Peters RW, et al. Optimization of atrial defibrillation with a dual-coil, active pectoral lead system. J Cardiovasc Electrophysiol. 2004;15(7):790–4.PubMedCrossRef
8.
go back to reference Van Noord T, Van Gelder IC, Crijns HJ. How to enhance acute outcome of electrical cardioversion by drug therapy: importance of immediate reinitiation of atrial fibrillation. J Cardiovasc Electrophysiol. 2002;13(8):822–5.PubMedCrossRef Van Noord T, Van Gelder IC, Crijns HJ. How to enhance acute outcome of electrical cardioversion by drug therapy: importance of immediate reinitiation of atrial fibrillation. J Cardiovasc Electrophysiol. 2002;13(8):822–5.PubMedCrossRef
9.
go back to reference Van Noord T, Van Gelder IC, Schoonderwoerd BA, et al. Immediate reinitiation of atrial fibrillation after electrical cardioversion predicts subsequent pharmacologic and electrical conversion to sinus rhythm and amiodarone. Am J Cardiol. 2000;86 12:1384–5, A5 Van Noord T, Van Gelder IC, Schoonderwoerd BA, et al. Immediate reinitiation of atrial fibrillation after electrical cardioversion predicts subsequent pharmacologic and electrical conversion to sinus rhythm and amiodarone. Am J Cardiol. 2000;86 12:1384–5, A5
10.
go back to reference Gold MR, Shih HT, Herre J, et al. Comparison of defibrillation efficacy and survival associated with right versus left pectoral placement for implantable defibrillators. Am J Cardiol. 2007;100(2):243–6.PubMedCrossRef Gold MR, Shih HT, Herre J, et al. Comparison of defibrillation efficacy and survival associated with right versus left pectoral placement for implantable defibrillators. Am J Cardiol. 2007;100(2):243–6.PubMedCrossRef
11.
go back to reference Levy S, Ricard P, Lau CP, et al. Multicenter low energy transvenous atrial defibrillation (XAD) trial results in different subsets of atrial fibrillation. J Am Coll Cardiol. 1997;29(4):750–5.PubMedCrossRef Levy S, Ricard P, Lau CP, et al. Multicenter low energy transvenous atrial defibrillation (XAD) trial results in different subsets of atrial fibrillation. J Am Coll Cardiol. 1997;29(4):750–5.PubMedCrossRef
12.
go back to reference Boriani G, Biffi M, Camanini C, et al. Efficacy of internal cardioversion for chronic atrial fibrillation in patients with and without left ventricular dysfunction. Int J Cardiol. 2004;95(1):43–7.PubMedCrossRef Boriani G, Biffi M, Camanini C, et al. Efficacy of internal cardioversion for chronic atrial fibrillation in patients with and without left ventricular dysfunction. Int J Cardiol. 2004;95(1):43–7.PubMedCrossRef
13.
go back to reference Tse HF, Lau CP. Safety and efficacy of internal cardioversion of atrial fibrillation in patients with impaired left ventricular systolic function. Am J Cardiol. 1999;84 9:1090–2, A9. Tse HF, Lau CP. Safety and efficacy of internal cardioversion of atrial fibrillation in patients with impaired left ventricular systolic function. Am J Cardiol. 1999;84 9:1090–2, A9.
14.
go back to reference Neuzner J, Carlsson J. Dual- versus single-coil implantable defibrillator leads: review of the literature. Clin Res Cardiol. 2012;101(4):239–45.PubMedCrossRef Neuzner J, Carlsson J. Dual- versus single-coil implantable defibrillator leads: review of the literature. Clin Res Cardiol. 2012;101(4):239–45.PubMedCrossRef
15.
go back to reference Bracke F. Complications and lead extraction in cardiac pacing and defibrillation. Neth Heart J. 2008;16 Suppl 1:S28–31.PubMed Bracke F. Complications and lead extraction in cardiac pacing and defibrillation. Neth Heart J. 2008;16 Suppl 1:S28–31.PubMed
16.
go back to reference Frick M, Frykman V, Jensen-Urstad M, et al. Factors predicting success rate and recurrence of atrial fibrillation after first electrical cardioversion in patients with persistent atrial fibrillation. Clin Cardiol. 2001;24(3):238–44.PubMedCrossRef Frick M, Frykman V, Jensen-Urstad M, et al. Factors predicting success rate and recurrence of atrial fibrillation after first electrical cardioversion in patients with persistent atrial fibrillation. Clin Cardiol. 2001;24(3):238–44.PubMedCrossRef
17.
go back to reference Mittal S, Ayati S, Stein KM, et al. Transthoracic cardioversion of atrial fibrillation: comparison of rectilinear biphasic versus damped sine wave monophasic shocks. Circulation. 2000;101(11):1282–7.PubMedCrossRef Mittal S, Ayati S, Stein KM, et al. Transthoracic cardioversion of atrial fibrillation: comparison of rectilinear biphasic versus damped sine wave monophasic shocks. Circulation. 2000;101(11):1282–7.PubMedCrossRef
18.
go back to reference Van Gelder IC, Crijns HJ, Van Gilst WH, et al. Prediction of uneventful cardioversion and maintenance of sinus rhythm from direct-current electrical cardioversion of chronic atrial fibrillation and flutter. Am J Cardiol. 1991;68(1):41–6.PubMedCrossRef Van Gelder IC, Crijns HJ, Van Gilst WH, et al. Prediction of uneventful cardioversion and maintenance of sinus rhythm from direct-current electrical cardioversion of chronic atrial fibrillation and flutter. Am J Cardiol. 1991;68(1):41–6.PubMedCrossRef
19.
go back to reference Boahene KA, Klein GJ, Yee R, et al. Termination of acute atrial fibrillation in the Wolff-Parkinson-White syndrome by procainamide and propafenone: importance of atrial fibrillatory cycle length. J Am Coll Cardiol. 1990;16(6):1408–14.PubMedCrossRef Boahene KA, Klein GJ, Yee R, et al. Termination of acute atrial fibrillation in the Wolff-Parkinson-White syndrome by procainamide and propafenone: importance of atrial fibrillatory cycle length. J Am Coll Cardiol. 1990;16(6):1408–14.PubMedCrossRef
20.
go back to reference Capucci A, Biffi M, Boriani G, et al. Dynamic electrophysiological behavior of human atria during paroxysmal atrial fibrillation. Circulation. 1995;92(5):1193–202.PubMedCrossRef Capucci A, Biffi M, Boriani G, et al. Dynamic electrophysiological behavior of human atria during paroxysmal atrial fibrillation. Circulation. 1995;92(5):1193–202.PubMedCrossRef
21.
go back to reference Haissaguerre M, Lim KT, Jacquemet V, et al. Atrial fibrillatory cycle length: computer simulation and potential clinical importance. Europace. 2007;9 Suppl 6:vi64–70.PubMedCrossRef Haissaguerre M, Lim KT, Jacquemet V, et al. Atrial fibrillatory cycle length: computer simulation and potential clinical importance. Europace. 2007;9 Suppl 6:vi64–70.PubMedCrossRef
22.
go back to reference Wijffels MC, Kirchhof CJ, Dorland R, et al. Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. Circulation. 1995;92(7):1954–68.PubMedCrossRef Wijffels MC, Kirchhof CJ, Dorland R, et al. Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. Circulation. 1995;92(7):1954–68.PubMedCrossRef
23.
go back to reference Kim SK, Pak HN, Park JH, et al. Clinical and serological predictors for the recurrence of atrial fibrillation after electrical cardioversion. Europace. 2009;11(12):1632–8.PubMedCrossRef Kim SK, Pak HN, Park JH, et al. Clinical and serological predictors for the recurrence of atrial fibrillation after electrical cardioversion. Europace. 2009;11(12):1632–8.PubMedCrossRef
24.
go back to reference Anter E, Jessup M, Callans DJ. Atrial fibrillation and heart failure: treatment considerations for a dual epidemic. Circulation. 2009;119(18):2516–25.PubMedCrossRef Anter E, Jessup M, Callans DJ. Atrial fibrillation and heart failure: treatment considerations for a dual epidemic. Circulation. 2009;119(18):2516–25.PubMedCrossRef
25.
go back to reference Maisel WH, Stevenson LW. Atrial fibrillation in heart failure: epidemiology, pathophysiology, and rationale for therapy. Am J Cardiol. 2003;91(6A):2D–8.PubMedCrossRef Maisel WH, Stevenson LW. Atrial fibrillation in heart failure: epidemiology, pathophysiology, and rationale for therapy. Am J Cardiol. 2003;91(6A):2D–8.PubMedCrossRef
26.
go back to reference McManus DD, Shaikh AY, Abhishek F, et al. Atrial fibrillation and heart failure parallels: lessons for atrial fibrillation prevention. Crit Pathw Cardiol. 2011;10(1):46–51.PubMedCrossRef McManus DD, Shaikh AY, Abhishek F, et al. Atrial fibrillation and heart failure parallels: lessons for atrial fibrillation prevention. Crit Pathw Cardiol. 2011;10(1):46–51.PubMedCrossRef
Metadata
Title
Low efficacy of cardioversion of persistent atrial fibrillation with the implantable cardioverter-defibrillator
Authors
I. Limantoro
K. Vernooy
B. Weijs
R. Pisters
L. Debie
H. J. Crijns
Y. Blaauw
Publication date
01-12-2013
Publisher
Bohn Stafleu van Loghum
Published in
Netherlands Heart Journal / Issue 12/2013
Print ISSN: 1568-5888
Electronic ISSN: 1876-6250
DOI
https://doi.org/10.1007/s12471-013-0474-z

Other articles of this Issue 12/2013

Netherlands Heart Journal 12/2013 Go to the issue

Editor's comment

Let’s talk about sex